Trastuzumab Recruiting Phase 1 / 2 Trials for HER-2 Positive Breast Cancer / Carcinoma, Breast / Metastatic Breast Cancer (MBC) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs